The Effectiveness and Safety of a Homeopathic Medicinal Product in Pediatric Upper Respiratory Tract Infections With Fever

We investigated the clinical effectiveness of a homeopathic add-on therapy in a pediatric subpopulation with upper respiratory tract infections (URTI) in a randomized, controlled, multinational clinical trial. Patients received either on-demand symptomatic standard treatment (ST-group) or the same S...

Full description

Saved in:
Bibliographic Details
Published in:Global pediatric health 2016-06, Vol.3
Main Authors: van Haselen Robert, Thinesse-Mallwitz Manuela, Maidannyk Vitaliy, Buskin, Stephen L, Weber, Stephan, Keller, Thomas, Burkart, Julia, Klement Petra
Format: Article
Language:English
Subjects:
Fever
Pediatrics
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c1831-700072acf899401169dc1fa1d94b195033aace42cfded1fcbbcc1c2717159baf3
cites
container_end_page
container_issue
container_start_page
container_title Global pediatric health
container_volume 3
creator van Haselen Robert
Thinesse-Mallwitz Manuela
Maidannyk Vitaliy
Buskin, Stephen L
Weber, Stephan
Keller, Thomas
Burkart, Julia
Klement Petra
description We investigated the clinical effectiveness of a homeopathic add-on therapy in a pediatric subpopulation with upper respiratory tract infections (URTI) in a randomized, controlled, multinational clinical trial. Patients received either on-demand symptomatic standard treatment (ST-group) or the same ST plus a homeopathic medication (Influcid; IFC-group) for 7 days. Outcome assessment was based on symptom and fever resolution and the Wisconsin Upper Respiratory Symptom Survey–21 (WURSS-21). A total of 261 pediatric (
doi_str_mv 10.1177/2333794X16654851
format article
fullrecord <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_2bda97fbe921431e8ab80a893424422a</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_2bda97fbe921431e8ab80a893424422a</doaj_id><sourcerecordid>2424769073</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1831-700072acf899401169dc1fa1d94b195033aace42cfded1fcbbcc1c2717159baf3</originalsourceid><addsrcrecordid>eNotkE1LAzEQhhdBULR3jwHP1UySbTZHET8KikUreltmk4lNqZs1SYX6610_TgPPvDwzvFV1AvwMQOtzIaXURr3CbFarpoa96vAHTX_YQTXJec05B6lqXovD6mu5InblPdkSPqmnnBn2jj2hp7Jj0TNkt_Gd4oBlFSy7Jxds6HHDFim6rS0s9GwxQixpXD8PAyX2SHkICUtMO7ZMOIbm_e-B2Gf2EsqKXdMnpeNq3-Mm0-R_HlXP11fLy9vp3cPN_PLibmqhkTDV47taoPWNMYoDzIyz4BGcUR2YmkuJaEkJ6x058LbrrAUrNGioTYdeHlXzP6-LuG6HFN4x7dqIof0FMb21mEqwG2pF59Bo35ERoCRQg13DsTFSCaWEwNF1-ucaUvzYUi7tOm7T2EduxZjRM8O1lN8DBXgP</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2424769073</pqid></control><display><type>article</type><title>The Effectiveness and Safety of a Homeopathic Medicinal Product in Pediatric Upper Respiratory Tract Infections With Fever</title><source>Publicly Available Content Database</source><source>PMC (PubMed Central)</source><source>Sage Journals GOLD Open Access 2024</source><creator>van Haselen Robert ; Thinesse-Mallwitz Manuela ; Maidannyk Vitaliy ; Buskin, Stephen L ; Weber, Stephan ; Keller, Thomas ; Burkart, Julia ; Klement Petra</creator><creatorcontrib>van Haselen Robert ; Thinesse-Mallwitz Manuela ; Maidannyk Vitaliy ; Buskin, Stephen L ; Weber, Stephan ; Keller, Thomas ; Burkart, Julia ; Klement Petra</creatorcontrib><description>We investigated the clinical effectiveness of a homeopathic add-on therapy in a pediatric subpopulation with upper respiratory tract infections (URTI) in a randomized, controlled, multinational clinical trial. Patients received either on-demand symptomatic standard treatment (ST-group) or the same ST plus a homeopathic medication (Influcid; IFC-group) for 7 days. Outcome assessment was based on symptom and fever resolution and the Wisconsin Upper Respiratory Symptom Survey–21 (WURSS-21). A total of 261 pediatric (&lt;12 years) patients (130 IFC-group; 131 ST-group) were recruited in Germany and the Ukraine. The IFC-group used less symptomatic medication, symptoms resolved significantly earlier (P = .0001), had higher proportions of fever-free children from day 3 onwards, and the WURSS-assessed global disease severity was significantly less (P &lt; .0001) during the entire URTI episode. One adverse event (vomiting) was possibly related to IFC. IFC as add-on treatment in pediatric URTI reduced global disease severity, shortened symptom resolution, and was safe in use.</description><identifier>EISSN: 2333-794X</identifier><identifier>DOI: 10.1177/2333794X16654851</identifier><language>eng</language><publisher>Thousand Oaks: Sage Publications Ltd</publisher><subject>Fever ; Pediatrics</subject><ispartof>Global pediatric health, 2016-06, Vol.3</ispartof><rights>The Author(s) 2016. This work is licensed under the Creative Commons Attribution – Non-Commercial License http://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c1831-700072acf899401169dc1fa1d94b195033aace42cfded1fcbbcc1c2717159baf3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.proquest.com/docview/2424769073?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>314,776,780,25732,27903,27904,36991,44569</link.rule.ids></links><search><creatorcontrib>van Haselen Robert</creatorcontrib><creatorcontrib>Thinesse-Mallwitz Manuela</creatorcontrib><creatorcontrib>Maidannyk Vitaliy</creatorcontrib><creatorcontrib>Buskin, Stephen L</creatorcontrib><creatorcontrib>Weber, Stephan</creatorcontrib><creatorcontrib>Keller, Thomas</creatorcontrib><creatorcontrib>Burkart, Julia</creatorcontrib><creatorcontrib>Klement Petra</creatorcontrib><title>The Effectiveness and Safety of a Homeopathic Medicinal Product in Pediatric Upper Respiratory Tract Infections With Fever</title><title>Global pediatric health</title><description>We investigated the clinical effectiveness of a homeopathic add-on therapy in a pediatric subpopulation with upper respiratory tract infections (URTI) in a randomized, controlled, multinational clinical trial. Patients received either on-demand symptomatic standard treatment (ST-group) or the same ST plus a homeopathic medication (Influcid; IFC-group) for 7 days. Outcome assessment was based on symptom and fever resolution and the Wisconsin Upper Respiratory Symptom Survey–21 (WURSS-21). A total of 261 pediatric (&lt;12 years) patients (130 IFC-group; 131 ST-group) were recruited in Germany and the Ukraine. The IFC-group used less symptomatic medication, symptoms resolved significantly earlier (P = .0001), had higher proportions of fever-free children from day 3 onwards, and the WURSS-assessed global disease severity was significantly less (P &lt; .0001) during the entire URTI episode. One adverse event (vomiting) was possibly related to IFC. IFC as add-on treatment in pediatric URTI reduced global disease severity, shortened symptom resolution, and was safe in use.</description><subject>Fever</subject><subject>Pediatrics</subject><issn>2333-794X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNotkE1LAzEQhhdBULR3jwHP1UySbTZHET8KikUreltmk4lNqZs1SYX6610_TgPPvDwzvFV1AvwMQOtzIaXURr3CbFarpoa96vAHTX_YQTXJec05B6lqXovD6mu5InblPdkSPqmnnBn2jj2hp7Jj0TNkt_Gd4oBlFSy7Jxds6HHDFim6rS0s9GwxQixpXD8PAyX2SHkICUtMO7ZMOIbm_e-B2Gf2EsqKXdMnpeNq3-Mm0-R_HlXP11fLy9vp3cPN_PLibmqhkTDV47taoPWNMYoDzIyz4BGcUR2YmkuJaEkJ6x058LbrrAUrNGioTYdeHlXzP6-LuG6HFN4x7dqIof0FMb21mEqwG2pF59Bo35ERoCRQg13DsTFSCaWEwNF1-ucaUvzYUi7tOm7T2EduxZjRM8O1lN8DBXgP</recordid><startdate>20160601</startdate><enddate>20160601</enddate><creator>van Haselen Robert</creator><creator>Thinesse-Mallwitz Manuela</creator><creator>Maidannyk Vitaliy</creator><creator>Buskin, Stephen L</creator><creator>Weber, Stephan</creator><creator>Keller, Thomas</creator><creator>Burkart, Julia</creator><creator>Klement Petra</creator><general>Sage Publications Ltd</general><general>SAGE Publishing</general><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>DOA</scope></search><sort><creationdate>20160601</creationdate><title>The Effectiveness and Safety of a Homeopathic Medicinal Product in Pediatric Upper Respiratory Tract Infections With Fever</title><author>van Haselen Robert ; Thinesse-Mallwitz Manuela ; Maidannyk Vitaliy ; Buskin, Stephen L ; Weber, Stephan ; Keller, Thomas ; Burkart, Julia ; Klement Petra</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1831-700072acf899401169dc1fa1d94b195033aace42cfded1fcbbcc1c2717159baf3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Fever</topic><topic>Pediatrics</topic><toplevel>online_resources</toplevel><creatorcontrib>van Haselen Robert</creatorcontrib><creatorcontrib>Thinesse-Mallwitz Manuela</creatorcontrib><creatorcontrib>Maidannyk Vitaliy</creatorcontrib><creatorcontrib>Buskin, Stephen L</creatorcontrib><creatorcontrib>Weber, Stephan</creatorcontrib><creatorcontrib>Keller, Thomas</creatorcontrib><creatorcontrib>Burkart, Julia</creatorcontrib><creatorcontrib>Klement Petra</creatorcontrib><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Global pediatric health</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>van Haselen Robert</au><au>Thinesse-Mallwitz Manuela</au><au>Maidannyk Vitaliy</au><au>Buskin, Stephen L</au><au>Weber, Stephan</au><au>Keller, Thomas</au><au>Burkart, Julia</au><au>Klement Petra</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The Effectiveness and Safety of a Homeopathic Medicinal Product in Pediatric Upper Respiratory Tract Infections With Fever</atitle><jtitle>Global pediatric health</jtitle><date>2016-06-01</date><risdate>2016</risdate><volume>3</volume><eissn>2333-794X</eissn><abstract>We investigated the clinical effectiveness of a homeopathic add-on therapy in a pediatric subpopulation with upper respiratory tract infections (URTI) in a randomized, controlled, multinational clinical trial. Patients received either on-demand symptomatic standard treatment (ST-group) or the same ST plus a homeopathic medication (Influcid; IFC-group) for 7 days. Outcome assessment was based on symptom and fever resolution and the Wisconsin Upper Respiratory Symptom Survey–21 (WURSS-21). A total of 261 pediatric (&lt;12 years) patients (130 IFC-group; 131 ST-group) were recruited in Germany and the Ukraine. The IFC-group used less symptomatic medication, symptoms resolved significantly earlier (P = .0001), had higher proportions of fever-free children from day 3 onwards, and the WURSS-assessed global disease severity was significantly less (P &lt; .0001) during the entire URTI episode. One adverse event (vomiting) was possibly related to IFC. IFC as add-on treatment in pediatric URTI reduced global disease severity, shortened symptom resolution, and was safe in use.</abstract><cop>Thousand Oaks</cop><pub>Sage Publications Ltd</pub><doi>10.1177/2333794X16654851</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier EISSN: 2333-794X
ispartof Global pediatric health, 2016-06, Vol.3
issn 2333-794X
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_2bda97fbe921431e8ab80a893424422a
source Publicly Available Content Database; PMC (PubMed Central); Sage Journals GOLD Open Access 2024
subjects Fever
Pediatrics
title The Effectiveness and Safety of a Homeopathic Medicinal Product in Pediatric Upper Respiratory Tract Infections With Fever
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-25T22%3A02%3A23IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20Effectiveness%20and%20Safety%20of%20a%20Homeopathic%20Medicinal%20Product%20in%20Pediatric%20Upper%20Respiratory%20Tract%20Infections%20With%20Fever&rft.jtitle=Global%20pediatric%20health&rft.au=van%20Haselen%20Robert&rft.date=2016-06-01&rft.volume=3&rft.eissn=2333-794X&rft_id=info:doi/10.1177/2333794X16654851&rft_dat=%3Cproquest_doaj_%3E2424769073%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c1831-700072acf899401169dc1fa1d94b195033aace42cfded1fcbbcc1c2717159baf3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2424769073&rft_id=info:pmid/&rfr_iscdi=true